Evotec begins new Oxford Uni digital health partnership

08:50 EDT 24 Jun 2019 | pharmaphorum

Germany’s Evotec has begun a new strategic partnership with the British AI tech company Sensyne Health and Oxford University to translate research into new companies working on digital health, clinical AI algorithms and data-driven drug discovery and...

Original Article: Evotec begins new Oxford Uni digital health partnership


More From BioPortfolio on "Evotec begins new Oxford Uni digital health partnership"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...